Annual Meeting

Overview and Objectives

 

AOFAS Annual Meeting 2023

September 20-23, 2023
Kentucky International Convention Center
Louisville, Kentucky, USA

AOFAS President: Bryan D. Den Hartog, MD
Program Chair: Kenneth J. Hunt, MD
Pre-Meeting Chair: Rebecca A. Cerrato, MD

 


Who Should Attend?

This educational program is designed for orthopaedic surgeons, physicians, and allied health practitioners in the field of orthopaedic foot and ankle surgery.


Educational Objectives

At the conclusion of AOFAS Annual Meeting, learners should be able to:

  • Recognize and assess current data reflecting clinical trends, emerging surgical techniques, pre- and post-operative procedures, and technological innovations in orthopaedic foot and ankle surgery

  • Describe and apply current research in foot and ankle disorders to improve patient care

  • Identify ways to avoid potential complications in foot and ankle procedures

  • Incorporate knowledge of patient safety, outcomes, and evidence-based medicine into foot and ankle patient care


Statement of Need

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.


Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.


Disclaimer

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.


Disclosure of Conflict of Interest

Disclosure Statement
AOFAS mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All identified conflicts must be mitigated, and the education content vetted by the AOFAS for fair balance, scientific objectivity, and appropriateness. All disclosures will be provided in this final program distributed at the meeting to all program participants.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that "off label" uses of a drug or medical device may be described in its CME activities so long as the "off label" use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used "off label" if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related Board, committee members ("planners"), faculty, and appropriate staff disclose in writing to the learners all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant's disclosure appears after his or her name as well as the commercial company or institution that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author's participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best-available evidence.


Program Committee

Chair
Kenneth J. Hunt, MD

Annual Meeting Pre-Meeting Chair
Rebecca A. Cerrato, MD

Members
Jason T. Bariteau, MD, Research Committee Chair
Steven Behrens, MD
John T. Campbell, MD, Fellowship Match & Accreditation Committee Chair
Cesar de Cesar Netto, MD, PhD, Young Physicians Committee Chair
Christopher P. Chiodo, MD, Health Policy Committee Chair
Bopha Chrea, MD
Michael P. Clare, MD
M. Truitt Cooper, MD, OnDemand Education Committee Chair
A. Samuel Flemister, MD, Membership Committee Chair
David N. Garras, MD
Lauren E. Geaney, Education Committee Chair
Daniel Guss, MD, MBA (ex-officio)
Thomas G. Harris, MD
Jeannie Huh, MD, Evidence Based Medicine Committee Chair
Casey J. Humbyrd, MD (ex-officio)
Kelly K. Hynes, MD
Anish R. Kadakia, MD
Harold B. Kitaoka, MD
Sandra E. Klein, MD
Mohammed Mokhtar Abd-Ella, MD 
David I. Pedowitz, MD, Practice Management Committee Chair
Kristina Quirolgico, MD
Christopher W. Reb, DO
Sudheer C. Reddy, MD, Public Education Committee Chair
Chamnanni Rungprai, MD
Charles L. Saltzman, MD, FAI/FAO Editor-in-Chief (ex-officio)
Jeremy T. Smith, MD, International Outreach Committee Chair
Nicholas Strasser, MD
Gary W. Stewart, MD, Diversity, Equity, and Inclusion Committee Chair
Eric W. Tan, MD, Postgraduate Education Committee Chair

 

Claim CME/CE Credit
To claim continuing education credit for Annual Meeting 2023, please click here and select the in-person or virtual meeting.